IPO
-
-
-
-
-
-
-
Cortexyme Provides Regulatory Update for COR388 Development Program in Alzheimer’s Disease
-
-
-
-
-
-
-
Cortexyme to Present at the 3rd Annual Neuroscience Innovation Forum on January 12, 2020
-
-
-
-
-
-
-
Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019
-
-
-
-
-
-
-
Cortexyme, Inc. Announces Pricing of Initial Public Offering
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

